Table of Content

1 Market Overview of Refractory Multiple Myeloma
1.1 Refractory Multiple Myeloma Market Overview
1.1.1 Refractory Multiple Myeloma Product Scope
1.1.2 Refractory Multiple Myeloma Market Status and Outlook
1.2 Global Refractory Multiple Myeloma Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Refractory Multiple Myeloma Market Size by Region (2018-2033)
1.4 Global Refractory Multiple Myeloma Historic Market Size by Region (2018-2023)
1.5 Global Refractory Multiple Myeloma Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Refractory Multiple Myeloma Market Size (2018-2033)
1.6.1 North America Refractory Multiple Myeloma Market Size (2018-2033)
1.6.2 Europe Refractory Multiple Myeloma Market Size (2018-2033)
1.6.3 Asia-Pacific Refractory Multiple Myeloma Market Size (2018-2033)
1.6.4 Latin America Refractory Multiple Myeloma Market Size (2018-2033)
1.6.5 Middle East & Africa Refractory Multiple Myeloma Market Size (2018-2033)
2 Refractory Multiple Myeloma Market by Type
2.1 Introduction
2.1.1 Proteosome Inhibitor
2.1.2 Immunomodulators
2.1.3 Anti-CD38 Monoclonal Antibody
2.1.4 Others
2.2 Global Refractory Multiple Myeloma Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Refractory Multiple Myeloma Historic Market Size by Type (2018-2023)
2.2.2 Global Refractory Multiple Myeloma Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Refractory Multiple Myeloma Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Refractory Multiple Myeloma Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Refractory Multiple Myeloma Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Refractory Multiple Myeloma Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Refractory Multiple Myeloma Revenue Breakdown by Type (2018-2033)
3 Refractory Multiple Myeloma Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Specialty Clinic
3.1.3 Others
3.2 Global Refractory Multiple Myeloma Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Refractory Multiple Myeloma Historic Market Size by Application (2018-2023)
3.2.2 Global Refractory Multiple Myeloma Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Refractory Multiple Myeloma Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Refractory Multiple Myeloma Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Refractory Multiple Myeloma Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Refractory Multiple Myeloma Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Refractory Multiple Myeloma Revenue Breakdown by Application (2018-2033)
4 Refractory Multiple Myeloma Competition Analysis by Players
4.1 Global Refractory Multiple Myeloma Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Refractory Multiple Myeloma as of 2022)
4.3 Date of Key Players Enter into Refractory Multiple Myeloma Market
4.4 Global Top Players Refractory Multiple Myeloma Headquarters and Area Served
4.5 Key Players Refractory Multiple Myeloma Product Solution and Service
4.6 Competitive Status
4.6.1 Refractory Multiple Myeloma Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bristol Myers Squibb
5.1.1 Bristol Myers Squibb Profile
5.1.2 Bristol Myers Squibb Main Business
5.1.3 Bristol Myers Squibb Refractory Multiple Myeloma Products, Services and Solutions
5.1.4 Bristol Myers Squibb Refractory Multiple Myeloma Revenue (US$ Million) & (2018-2023)
5.1.5 Bristol Myers Squibb Recent Developments
5.2 Teva Pharmaceutical Industries Ltd.
5.2.1 Teva Pharmaceutical Industries Ltd. Profile
5.2.2 Teva Pharmaceutical Industries Ltd. Main Business
5.2.3 Teva Pharmaceutical Industries Ltd. Refractory Multiple Myeloma Products, Services and Solutions
5.2.4 Teva Pharmaceutical Industries Ltd. Refractory Multiple Myeloma Revenue (US$ Million) & (2018-2023)
5.2.5 Teva Pharmaceutical Industries Ltd. Recent Developments
5.3 Pfizer Inc.
5.3.1 Pfizer Inc. Profile
5.3.2 Pfizer Inc. Main Business
5.3.3 Pfizer Inc. Refractory Multiple Myeloma Products, Services and Solutions
5.3.4 Pfizer Inc. Refractory Multiple Myeloma Revenue (US$ Million) & (2018-2023)
5.3.5 Janssen Global Services, LLC Recent Developments
5.4 Janssen Global Services, LLC
5.4.1 Janssen Global Services, LLC Profile
5.4.2 Janssen Global Services, LLC Main Business
5.4.3 Janssen Global Services, LLC Refractory Multiple Myeloma Products, Services and Solutions
5.4.4 Janssen Global Services, LLC Refractory Multiple Myeloma Revenue (US$ Million) & (2018-2023)
5.4.5 Janssen Global Services, LLC Recent Developments
5.5 Gilead Sciences, Inc.
5.5.1 Gilead Sciences, Inc. Profile
5.5.2 Gilead Sciences, Inc. Main Business
5.5.3 Gilead Sciences, Inc. Refractory Multiple Myeloma Products, Services and Solutions
5.5.4 Gilead Sciences, Inc. Refractory Multiple Myeloma Revenue (US$ Million) & (2018-2023)
5.5.5 Gilead Sciences, Inc. Recent Developments
5.6 Fresenius Kabi
5.6.1 Fresenius Kabi Profile
5.6.2 Fresenius Kabi Main Business
5.6.3 Fresenius Kabi Refractory Multiple Myeloma Products, Services and Solutions
5.6.4 Fresenius Kabi Refractory Multiple Myeloma Revenue (US$ Million) & (2018-2023)
5.6.5 Fresenius Kabi Recent Developments
5.7 GSK plc.
5.7.1 GSK plc. Profile
5.7.2 GSK plc. Main Business
5.7.3 GSK plc. Refractory Multiple Myeloma Products, Services and Solutions
5.7.4 GSK plc. Refractory Multiple Myeloma Revenue (US$ Million) & (2018-2023)
5.7.5 GSK plc. Recent Developments
5.8 Novartis AG
5.8.1 Novartis AG Profile
5.8.2 Novartis AG Main Business
5.8.3 Novartis AG Refractory Multiple Myeloma Products, Services and Solutions
5.8.4 Novartis AG Refractory Multiple Myeloma Revenue (US$ Million) & (2018-2023)
5.8.5 Novartis AG Recent Developments
5.9 Takeda Pharmaceutical Company Limited
5.9.1 Takeda Pharmaceutical Company Limited Profile
5.9.2 Takeda Pharmaceutical Company Limited Main Business
5.9.3 Takeda Pharmaceutical Company Limited Refractory Multiple Myeloma Products, Services and Solutions
5.9.4 Takeda Pharmaceutical Company Limited Refractory Multiple Myeloma Revenue (US$ Million) & (2018-2023)
5.9.5 Takeda Pharmaceutical Company Limited Recent Developments
5.10 Genentech, Inc.
5.10.1 Genentech, Inc. Profile
5.10.2 Genentech, Inc. Main Business
5.10.3 Genentech, Inc. Refractory Multiple Myeloma Products, Services and Solutions
5.10.4 Genentech, Inc. Refractory Multiple Myeloma Revenue (US$ Million) & (2018-2023)
5.10.5 Genentech, Inc. Recent Developments
6 North America
6.1 North America Refractory Multiple Myeloma Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Refractory Multiple Myeloma Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Refractory Multiple Myeloma Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Refractory Multiple Myeloma Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Refractory Multiple Myeloma Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Refractory Multiple Myeloma Market Dynamics
11.1 Refractory Multiple Myeloma Industry Trends
11.2 Refractory Multiple Myeloma Market Drivers
11.3 Refractory Multiple Myeloma Market Challenges
11.4 Refractory Multiple Myeloma Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Refractory Multiple Myeloma Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Refractory Multiple Myeloma Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Refractory Multiple Myeloma Market Size Share by Region (2018-2023)
Table 4. Global Refractory Multiple Myeloma Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Refractory Multiple Myeloma Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Refractory Multiple Myeloma Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Refractory Multiple Myeloma Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Refractory Multiple Myeloma Revenue Market Share by Type (2018-2023)
Table 9. Global Refractory Multiple Myeloma Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Refractory Multiple Myeloma Revenue Market Share by Type (2024-2033)
Table 11. North America Refractory Multiple Myeloma Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Refractory Multiple Myeloma Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Refractory Multiple Myeloma Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Refractory Multiple Myeloma Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Refractory Multiple Myeloma Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Refractory Multiple Myeloma Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Refractory Multiple Myeloma Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Refractory Multiple Myeloma Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Refractory Multiple Myeloma Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Refractory Multiple Myeloma Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Refractory Multiple Myeloma Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Refractory Multiple Myeloma Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Refractory Multiple Myeloma Revenue Market Share by Application (2018-2023)
Table 24. Global Refractory Multiple Myeloma Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Refractory Multiple Myeloma Revenue Market Share by Application (2024-2033)
Table 26. North America Refractory Multiple Myeloma Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Refractory Multiple Myeloma Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Refractory Multiple Myeloma Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Refractory Multiple Myeloma Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Refractory Multiple Myeloma Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Refractory Multiple Myeloma Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Refractory Multiple Myeloma Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Refractory Multiple Myeloma Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Refractory Multiple Myeloma Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Refractory Multiple Myeloma Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Refractory Multiple Myeloma Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Refractory Multiple Myeloma Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Refractory Multiple Myeloma as of 2022)
Table 39. Date of Key Players Enter into Refractory Multiple Myeloma Market
Table 40. Global Refractory Multiple Myeloma Key Players Headquarters and Area Served
Table 41. Refractory Multiple Myeloma Product Solution and Service
Table 42. Global Refractory Multiple Myeloma Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Bristol Myers Squibb Basic Information List
Table 45. Bristol Myers Squibb Description and Business Overview
Table 46. Bristol Myers Squibb Refractory Multiple Myeloma Products, Services and Solutions
Table 47. Revenue (US$ Million) in Refractory Multiple Myeloma Business of Bristol Myers Squibb (2018-2023)
Table 48. Bristol Myers Squibb Recent Developments
Table 49. Teva Pharmaceutical Industries Ltd. Basic Information List
Table 50. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 51. Teva Pharmaceutical Industries Ltd. Refractory Multiple Myeloma Products, Services and Solutions
Table 52. Revenue (US$ Million) in Refractory Multiple Myeloma Business of Teva Pharmaceutical Industries Ltd. (2018-2023)
Table 53. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 54. Pfizer Inc. Basic Information List
Table 55. Pfizer Inc. Description and Business Overview
Table 56. Pfizer Inc. Refractory Multiple Myeloma Products, Services and Solutions
Table 57. Revenue (US$ Million) in Refractory Multiple Myeloma Business of Pfizer Inc. (2018-2023)
Table 58. Pfizer Inc. Recent Developments
Table 59. Janssen Global Services, LLC Basic Information List
Table 60. Janssen Global Services, LLC Description and Business Overview
Table 61. Janssen Global Services, LLC Refractory Multiple Myeloma Products, Services and Solutions
Table 62. Revenue (US$ Million) in Refractory Multiple Myeloma Business of Janssen Global Services, LLC (2018-2023)
Table 63. Janssen Global Services, LLC Recent Developments
Table 64. Gilead Sciences, Inc. Basic Information List
Table 65. Gilead Sciences, Inc. Description and Business Overview
Table 66. Gilead Sciences, Inc. Refractory Multiple Myeloma Products, Services and Solutions
Table 67. Revenue (US$ Million) in Refractory Multiple Myeloma Business of Gilead Sciences, Inc. (2018-2023)
Table 68. Gilead Sciences, Inc. Recent Developments
Table 69. Fresenius Kabi Basic Information List
Table 70. Fresenius Kabi Description and Business Overview
Table 71. Fresenius Kabi Refractory Multiple Myeloma Products, Services and Solutions
Table 72. Revenue (US$ Million) in Refractory Multiple Myeloma Business of Fresenius Kabi (2018-2023)
Table 73. Fresenius Kabi Recent Developments
Table 74. GSK plc. Basic Information List
Table 75. GSK plc. Description and Business Overview
Table 76. GSK plc. Refractory Multiple Myeloma Products, Services and Solutions
Table 77. Revenue (US$ Million) in Refractory Multiple Myeloma Business of GSK plc. (2018-2023)
Table 78. GSK plc. Recent Developments
Table 79. Novartis AG Basic Information List
Table 80. Novartis AG Description and Business Overview
Table 81. Novartis AG Refractory Multiple Myeloma Products, Services and Solutions
Table 82. Revenue (US$ Million) in Refractory Multiple Myeloma Business of Novartis AG (2018-2023)
Table 83. Novartis AG Recent Developments
Table 84. Takeda Pharmaceutical Company Limited Basic Information List
Table 85. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 86. Takeda Pharmaceutical Company Limited Refractory Multiple Myeloma Products, Services and Solutions
Table 87. Revenue (US$ Million) in Refractory Multiple Myeloma Business of Takeda Pharmaceutical Company Limited (2018-2023)
Table 88. Takeda Pharmaceutical Company Limited Recent Developments
Table 89. Genentech, Inc. Basic Information List
Table 90. Genentech, Inc. Description and Business Overview
Table 91. Genentech, Inc. Refractory Multiple Myeloma Products, Services and Solutions
Table 92. Revenue (US$ Million) in Refractory Multiple Myeloma Business of Genentech, Inc. (2018-2023)
Table 93. Genentech, Inc. Recent Developments
Table 94. North America Refractory Multiple Myeloma Market Size by Country (2018-2023) & (US$ Million)
Table 95. North America Refractory Multiple Myeloma Market Size by Country (2024-2033) & (US$ Million)
Table 96. Europe Refractory Multiple Myeloma Market Size by Country (2018-2023) & (US$ Million)
Table 97. Europe Refractory Multiple Myeloma Market Size by Country (2024-2033) & (US$ Million)
Table 98. Asia-Pacific Refractory Multiple Myeloma Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 99. Asia-Pacific Refractory Multiple Myeloma Market Size by Region (2018-2023) & (US$ Million)
Table 100. Asia-Pacific Refractory Multiple Myeloma Market Size by Region (2024-2033) & (US$ Million)
Table 101. Asia-Pacific Refractory Multiple Myeloma Market Share by Region (2018-2023)
Table 102. Asia-Pacific Refractory Multiple Myeloma Market Share by Region (2024-2033)
Table 103. Latin America Refractory Multiple Myeloma Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 104. Latin America Refractory Multiple Myeloma Market Size by Country (2018-2023) & (US$ Million)
Table 105. Latin America Refractory Multiple Myeloma Market Size by Country (2024-2033) & (US$ Million)
Table 106. Middle East & Africa Refractory Multiple Myeloma Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 107. Middle East & Africa Refractory Multiple Myeloma Market Size by Country (2018-2023) & (US$ Million)
Table 108. Middle East & Africa Refractory Multiple Myeloma Market Size by Country (2024-2033) & (US$ Million)
Table 109. Refractory Multiple Myeloma Market Trends
Table 110. Refractory Multiple Myeloma Market Drivers
Table 111. Refractory Multiple Myeloma Market Challenges
Table 112. Refractory Multiple Myeloma Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Refractory Multiple Myeloma Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Refractory Multiple Myeloma Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Refractory Multiple Myeloma Market Share by Regions: 2022 VS 2033
Figure 4. Global Refractory Multiple Myeloma Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Refractory Multiple Myeloma Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Refractory Multiple Myeloma Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Refractory Multiple Myeloma Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Refractory Multiple Myeloma Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Refractory Multiple Myeloma Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Proteosome Inhibitor
Figure 11. Global Proteosome Inhibitor Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Immunomodulators
Figure 13. Global Immunomodulators Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Anti-CD38 Monoclonal Antibody
Figure 15. Global Anti-CD38 Monoclonal Antibody Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Product Picture of Others
Figure 17. Global Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 18. Global Refractory Multiple Myeloma Market Size Share by Type: 2022 & 2033
Figure 19. North America Refractory Multiple Myeloma Revenue Market Share by Type (2018-2033)
Figure 20. Europe Refractory Multiple Myeloma Revenue Market Share by Type (2018-2033)
Figure 21. Asia-Pacific Refractory Multiple Myeloma Revenue Market Share by Type (2018-2033)
Figure 22. Latin America Refractory Multiple Myeloma Revenue Market Share by Type (2018-2033)
Figure 23. Middle East and Africa Refractory Multiple Myeloma Revenue Market Share by Type (2018-2033)
Figure 24. Hospital Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 25. Specialty Clinic Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 26. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 27. Global Refractory Multiple Myeloma Market Size Share by Application: 2022 & 2033
Figure 28. North America Refractory Multiple Myeloma Revenue Market Share by Application (2018-2033)
Figure 29. Europe Refractory Multiple Myeloma Revenue Market Share by Application (2018-2033)
Figure 30. Asia-Pacific Refractory Multiple Myeloma Revenue Market Share by Application (2018-2033)
Figure 31. Latin America Refractory Multiple Myeloma Revenue Market Share by Application (2018-2033)
Figure 32. Middle East and Africa Refractory Multiple Myeloma Revenue Market Share by Application (2018-2033)
Figure 33. Refractory Multiple Myeloma Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 34. Global Top 5 and Top 10 Players Refractory Multiple Myeloma Market Share in 2022
Figure 35. North America Refractory Multiple Myeloma Market Share by Country (2018-2033)
Figure 36. United States Refractory Multiple Myeloma Market Size (2018-2033) & (US$ Million)
Figure 37. Canada Refractory Multiple Myeloma Market Size (2018-2033) & (US$ Million)
Figure 38. Germany Refractory Multiple Myeloma Market Size (2018-2033) & (US$ Million)
Figure 39. France Refractory Multiple Myeloma Market Size (2018-2033) & (US$ Million)
Figure 40. U.K. Refractory Multiple Myeloma Market Size (2018-2033) & (US$ Million)
Figure 41. Italy Refractory Multiple Myeloma Market Size (2018-2033) & (US$ Million)
Figure 42. Russia Refractory Multiple Myeloma Market Size (2018-2033) & (US$ Million)
Figure 43. Nordic Countries Refractory Multiple Myeloma Market Size (2018-2033) & (US$ Million)
Figure 44. Asia-Pacific Refractory Multiple Myeloma Market Share by Region (2018-2033)
Figure 45. China Refractory Multiple Myeloma Market Size (2018-2033) & (US$ Million)
Figure 46. Japan Refractory Multiple Myeloma Market Size (2018-2033) & (US$ Million)
Figure 47. South Korea Refractory Multiple Myeloma Market Size (2018-2033) & (US$ Million)
Figure 48. Southeast Asia Refractory Multiple Myeloma Market Size (2018-2033) & (US$ Million)
Figure 49. India Refractory Multiple Myeloma Market Size (2018-2033) & (US$ Million)
Figure 50. Australia Refractory Multiple Myeloma Market Size (2018-2033) & (US$ Million)
Figure 51. Latin America Refractory Multiple Myeloma Market Share by Country (2018-2033)
Figure 52. Mexico Refractory Multiple Myeloma Market Size (2018-2033) & (US$ Million)
Figure 53. Brazil Refractory Multiple Myeloma Market Size (2018-2033) & (US$ Million)
Figure 54. Middle East & Africa Refractory Multiple Myeloma Market Share by Country (2018-2033)
Figure 55. Turkey Refractory Multiple Myeloma Market Size (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia Refractory Multiple Myeloma Market Size (2018-2033) & (US$ Million)
Figure 57. UAE Refractory Multiple Myeloma Market Size (2018-2033) & (US$ Million)
Figure 58. Bottom-up and Top-down Approaches for This Report